Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidant Agrees With OIG To Educate Employees, Promote Reporting

This article was originally published in The Gray Sheet

Executive Summary

Guidant will sidestep the more onerous requirements of its 1Corporate Integrity Agreement with HHS by dissolving its EVT division this fall

You may also be interested in...



Senate Probes Guidant’s Compliance With Its Corporate Integrity Agreement

Senate Finance Committee Chair Chuck Grassley (R-Iowa) is investigating the recent series of Guidant device recalls to determine if the company violated the terms of its 2003 Corporate Integrity Agreement (CIA)

Senate Probes Guidant’s Compliance With Its Corporate Integrity Agreement

Senate Finance Committee Chair Chuck Grassley (R-Iowa) is investigating the recent series of Guidant device recalls to determine if the company violated the terms of its 2003 Corporate Integrity Agreement (CIA)

Business Effectiveness Cited As Key Component Of Compliance Programs

Business considerations are as important as legal requirements for effective compliance programs, TAP Pharmaceutical Products VP and Ethics & Compliance Officer Stephan Vincze said Sept. 14 at a Food & Drug Law Institute meeting in Washington, D.C

Related Content

UsernamePublicRestriction

Register

MT018658

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel